Search research articles
Contact Us
Filters
Showing results (321-330 of 326) with videos related to
Page
of 33
Sort By:
You have reached the last page of results.
This site can display upto 326 results.
Contemporary Clinical Trials
|
January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Nature Medicine
|
October 3, 2017
Defining total-body AIDS-virus burden with implications for curative strategies
Jacob D Estes, Cissy Kityo, Francis Ssali, et al.
Elife
|
July 4, 2018
Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis
Mark G Jones, Orestis G Andriotis, James Jw Roberts, et al.
The Journal of Infectious Diseases
|
June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
Matthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 22, 2026
Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial
Jason V Baker, Lianne Siegel, Marcelo Losso, et al.
ERJ Open Research
|
January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
Giles Dixon, Samuel Hague, Sarah Mulholland, et al.
Page
of 33
Search research articles
Search
Showing results (321-330 of 326) with videos related to
Sort By:
Page
of 33
You have reached the last page of results.
This site can display upto 326 results.
Contemporary Clinical Trials
|
January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Nature Medicine
|
October 3, 2017
Defining total-body AIDS-virus burden with implications for curative strategies
Jacob D Estes, Cissy Kityo, Francis Ssali, et al.
Elife
|
July 4, 2018
Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis
Mark G Jones, Orestis G Andriotis, James Jw Roberts, et al.
The Journal of Infectious Diseases
|
June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
Matthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 22, 2026
Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial
Jason V Baker, Lianne Siegel, Marcelo Losso, et al.
ERJ Open Research
|
January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
Giles Dixon, Samuel Hague, Sarah Mulholland, et al.
Page
of 33